
LINK . SPRINGER . COM {
}
Title:
Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines? | Critical Care
Description:
No description found...
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {đ}
- Health & Fitness
- Science
- Education
Content Management System {đ}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of link.springer.com audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,182 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {đž}
We don't see any clear sign of profit-making.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {đ}
cancer, lung, article, care, immunotherapy, nsclc, intensive, unit, guillon, authors, privacy, cookies, data, prognosis, admission, triage, access, antoine, patients, icu, mab, tours, information, change, publish, research, search, open, heuzévourch, treatment, survival, therapeutic, trial, clinical, immune, inhibitors, pubmed, applicable, content, consent, policy, journal, download, manuscript, reckamp, nathalie, chemotherapy, checkpoint, approved, med,
Topics {âïž}
intensive care unit small-cell lung cancer article download pdf admission policy due privacy choices/manage cookies lung cancer prognosis triage criteria based creative commons license crit care 21 lung cancer host immune response european economic area improving dramatically leading antibody-based therapy humanized monoclonal antibody safety monitoring committee heuzé-vourc conditions privacy policy antoine guillon line therapeutic options high-quality consultation pd-l1-positive article guillon keynote-024 trial showed substantial clinical benefit immune checkpoint inhibitors accepting optional cookies mab immunotherapy revolution nhv contributed equally immunotherapy improves triage criteria increased survival rates triage guidelines journal finder publish pembrolizumab versus chemotherapy full access admission article number 18 programmed death 1 blocking antibodies privacy policy cancer patients article cite change due research books a applicable funding personal data optional cookies manage preferences
Questions {â}
- Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
- Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
Schema {đșïž}
WebPage:
mainEntity:
headline:Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
description:
datePublished:2017-01-27T00:00:00Z
dateModified:2017-01-27T00:00:00Z
pageStart:1
pageEnd:2
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13054-017-1602-8
keywords:
Lung Cancer
Intensive Care Unit
Intensive Care Unit Admission
Lung Cancer Mortality
Triage Criterion
Intensive / Critical Care Medicine
Emergency Medicine
image:
isPartOf:
name:Critical Care
issn:
1364-8535
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Antoine Guillon
url:http://orcid.org/0000-0002-4884-8620
affiliation:
name:CHRU de Tours, Service de Réanimation Polyvalente
address:
name:CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
type:PostalAddress
type:Organization
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Karen L. Reckamp
affiliation:
name:City of Hope Comprehensive Cancer Center
address:
name:City of Hope Comprehensive Cancer Center, Duarte, USA
type:PostalAddress
type:Organization
type:Person
name:Nathalie HeuzĂ©-Vourcâh
affiliation:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
description:
datePublished:2017-01-27T00:00:00Z
dateModified:2017-01-27T00:00:00Z
pageStart:1
pageEnd:2
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13054-017-1602-8
keywords:
Lung Cancer
Intensive Care Unit
Intensive Care Unit Admission
Lung Cancer Mortality
Triage Criterion
Intensive / Critical Care Medicine
Emergency Medicine
image:
isPartOf:
name:Critical Care
issn:
1364-8535
volumeNumber:21
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Antoine Guillon
url:http://orcid.org/0000-0002-4884-8620
affiliation:
name:CHRU de Tours, Service de Réanimation Polyvalente
address:
name:CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
type:PostalAddress
type:Organization
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Karen L. Reckamp
affiliation:
name:City of Hope Comprehensive Cancer Center
address:
name:City of Hope Comprehensive Cancer Center, Duarte, USA
type:PostalAddress
type:Organization
type:Person
name:Nathalie HeuzĂ©-Vourcâh
affiliation:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Critical Care
issn:
1364-8535
volumeNumber:21
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:CHRU de Tours, Service de Réanimation Polyvalente
address:
name:CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
type:PostalAddress
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
name:City of Hope Comprehensive Cancer Center
address:
name:City of Hope Comprehensive Cancer Center, Duarte, USA
type:PostalAddress
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Antoine Guillon
url:http://orcid.org/0000-0002-4884-8620
affiliation:
name:CHRU de Tours, Service de Réanimation Polyvalente
address:
name:CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
type:PostalAddress
type:Organization
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
email:[email protected]
name:Karen L. Reckamp
affiliation:
name:City of Hope Comprehensive Cancer Center
address:
name:City of Hope Comprehensive Cancer Center, Duarte, USA
type:PostalAddress
type:Organization
name:Nathalie HeuzĂ©-Vourcâh
affiliation:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100
address:
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
type:PostalAddress
type:Organization
name:Université François Rabelais de Tours
address:
name:Université François Rabelais de Tours, Tours, France
type:PostalAddress
type:Organization
PostalAddress:
name:CHRU de Tours, Service de Réanimation Polyvalente, Tours, France
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
name:Université François Rabelais de Tours, Tours, France
name:City of Hope Comprehensive Cancer Center, Duarte, USA
name:INSERM, Centre dâĂtude des Pathologies Respiratoires, U1100, Tours, France
name:Université François Rabelais de Tours, Tours, France
External Links {đ}(44)
- What is the monthly revenue of https://www.springernature.com/gp/authors?
- https://link.springernature.com/home/'s financial summary
- Explore the financials of https://order.springer.com/public/cart
- Explore the financials of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- https://ccforum.biomedcentral.com/about's total income per month
- What's the income generated by https://submission.nature.com/new-submission/13054/3 each month?
- What's the revenue for https://orcid.org/0000-0002-4884-8620?
- Get to know what's the income of https://doi.org/10.1056%2FNEJMoa1606774
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27718847 generate?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20versus%20chemotherapy%20for%20PD-L1-positive%20non-small-cell%20lung%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1606774&volume=375&pages=1823-33&publication_year=2016&author=Reck%2CM&author=Rodr%C3%ADguez-Abreu%2CD&author=Robinson%2CAG&author=Hui%2CR&author=Cs%C5%91szi%2CT&author=F%C3%BCl%C3%B6p%2CA
- Discover the revenue of https://doi.org/10.1177%2F1758834016661164
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27800034
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066544 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Checkpoint%20inhibitors%20in%20lung%20cancer%3A%20latest%20developments%20and%20clinical%20potential&journal=Ther%20Adv%20Med%20Oncol&doi=10.1177%2F1758834016661164&volume=8&pages=460-73&publication_year=2016&author=Schvartsman%2CG&author=Ferrarotto%2CR&author=Massarelli%2CE?
- What's the financial outcome of https://doi.org/10.1056%2FNEJMoa061884?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17167137's gross income?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Paclitaxel-carboplatin%20alone%20or%20with%20bevacizumab%20for%20non-small-cell%20lung%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa061884&volume=355&pages=2542-50&publication_year=2006&author=Sandler%2CA&author=Gray%2CR&author=Perry%2CMC&author=Brahmer%2CJ&author=Schiller%2CJH&author=Dowlati%2CA generate?
- Explore the financials of https://citation-needed.springer.com/v2/references/10.1186/s13054-017-1602-8?format=refman&flavour=references
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Antoine%20Guillon?
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Antoine%20Guillon%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karen%20L.%20Reckamp?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karen%20L.%20Reckamp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nathalie%20Heuz%C3%A9-Vourc%E2%80%99h net monthly?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nathalie%20Heuz%C3%A9-Vourc%E2%80%99h%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does http://creativecommons.org/licenses/by/4.0/ pull in?
- Check the income stats for http://creativecommons.org/publicdomain/zero/1.0/
- Find out how much https://s100.copyright.com/AppDispatchServlet?title=Immunotherapy%20improves%20the%20prognosis%20of%20lung%20cancer%3A%20do%20we%20have%20to%20change%20intensive%20care%20unit%20admission%20and%20triage%20guidelines%3F&author=Antoine%20Guillon%20et%20al&contentID=10.1186%2Fs13054-017-1602-8©right=The%20Author%28s%29.&publication=1364-8535&publicationDate=2017-01-27&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 earns monthly
- How much revenue does https://crossmark.crossref.org/dialog/?doi=10.1186/s13054-017-1602-8 produce monthly?
- What's the financial gain of https://citation-needed.springer.com/v2/references/10.1186/s13054-017-1602-8?format=refman&flavour=citation?
- What's the monthly income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- What are the total earnings of https://www.springernature.com/gp/products?
- What's the revenue for https://www.springernature.com/gp/librarians?
- How much cash flow does https://www.springernature.com/gp/societies have monthly?
- See how much https://www.springernature.com/gp/partners makes per month
- Earnings of https://www.springer.com/
- How much does https://www.nature.com/ generate monthly?
- Explore the financials of https://www.biomedcentral.com/
- How much does https://www.palgrave.com/ rake in every month?
- What is the monthly revenue of https://www.apress.com/?
- How much does https://www.springernature.com/gp/legal/ccpa make?
- How much does https://www.springernature.com/gp/info/accessibility pull in monthly?
- How much does https://support.springernature.com/en/support/home net monthly?
- Get to know https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's earnings
- How much profit is https://www.springernature.com/ making per month?
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Prism.js
CDN Services {đŠ}
- Crossref